This inventor holds 2 USPTO granted patents. Top assignees: Research Foundation for Mental Hygiene, Inc., Yeda Research and Develpment & Co. Ltd. Active years: 1984-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 45 
2 out of 1,168 Years Active: 1984-1987
Title: Innovations by Stephen E. Karpiak: A Focus on Analgesia
Introduction
Stephen E. Karpiak, an innovative inventor based in New York, NY, is recognized for his contributions to the field of analgesics. With two patents to his name, Karpiak's work centers around the development of derivatives of 5-hydroxytryptophan, which have significant implications for pain management.
Latest Patents
Karpiak's latest patents include N-acylated 5-hydroxytryptophan amide derivatives. These derivatives are designed to provide analgesia effects and are characterized by the formulae that include variations of R, selected from a variety of aliphatic and aromatic alkyl groups. Specifically, these groups range from C2 to C16 alkyl, C3 to C8 cycloalkyl, as well as C2 to C16 alkenyl and alkynyl. Additionally, he introduced N-hexanoyl to n-heptadecanoyl 5-hydroxy derivatives, also structured to deliver analgesia through similar chemical configurations.
Career Highlights
Throughout his career, Stephen E. Karpiak has made significant strides in the research field. He has worked with notable organizations, including the Research Foundation for Mental Hygiene, Inc. and Yeda Research and Development Company. His research has played an essential role in the advancement of medications aimed at pain relief.
Collaborations
Karpiak's innovations have been enriched through collaborations with esteemed colleagues such as Hadassah Tamir and Meir Wilchek. Their collective expertise has contributed to the success of the patents developed by Karpiak and further underscores the importance of teamwork in scientific research.
Conclusion
In summary, Stephen E. Karpiak's advancements in developing analgesia-effective compositions illustrate the potential for innovation within the pharmaceutical industry. His patents not only highlight the efficacy of 5-hydroxytryptophan derivatives but also reflect a commitment to improving pain management solutions. As research continues to evolve, Karpiak's contributions will undoubtedly leave a lasting impact on the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile